IRMD vs MSCI · P/E 51, rev $42.4M vs P/E 37, rev $1.72B
Iradimed Co (IRMD) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Iradimed Co (IRMD) is a medical devices company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported IRMD revenue for 2026-06-30 was $42.4M. Net income was $11.0M. Revenue was up 93.1% from 2026-03-31 to 2026-06-30. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
IRMD currently screens at market cap $1.19B and trailing P/E 50.9. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the IRMD and MSCI stock pages for the full models.
Not investment advice.